Delivery Order SPE2DB22D3016-SPE2DB25FBJN7
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 24, 2025, for LIALDA DR 1.2 GM Tablet 120s, a pharmaceutical product used in the treatment of inflammatory bowel disease. This competitively awarded, firm fixed-price contract carries a ceiling value of $8,154.24 and is scheduled for completion by July 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- This is a $1,471.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIALDA DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract has a completion date of July 10, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply LIALDA DR 1.2 GM tablets. The order, valued at $2,444.37, requires delivery of 120 tablets to a facility located in Conshohocken, Pennsylvania by November 21, 2023. No set aside designation was applied to this award made against an indefinite delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to various...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,150 units of the prescription drug Lialda (mesalamine) in 120-count tablet bottles. The $2,807.73 firm fixed-price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...
- This federal contract award, valued at $22,741.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,566,065,418 tablets of the prescription medication Lialda, a 1.2 gram delayed-release tablet, in quantities of 120 per package. This is a firm-fixed price delivery order contract with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,217 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the order. No set-aside designation or subcontracting details were provided. The Defense Logistics Agency routinely procures medical...
- The Defense Logistics Agency Troop Support Medical awarded a $4,730 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA, an ulcerative colitis medication. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's Corporate Office Division. The order was placed on July 12, 2023 and fulfillment is required by July 13, 2023 to support DLA's medical supply chain responsibilities on behalf of the Department of Defense. No...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,036.18 from the Defense Logistics Agency Troop Support Medical to supply 120 tablets of 1.2 gm LIALDA DR tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by December 19, 2023. This order was awarded against an indefinite delivery contract between Amerisourcebergen Drug Corp and the Department of Justice Federal Bureau of Investigation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIALDA DR 1.2 GM TABLET 120S, which are likely pharmaceutical products. The contract has a ceiling value of $1,712.95 and a completion date of May 19, 2025. It is a firm fixed-price contract and is not set aside for any specific business type. Amerisourcebergen Drug Corp is the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,514.61 for the supply of the pharmaceutical product LIALDA DR 1.2 GM TABLET 120S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...